ATLASXenon Pharmaceuticals (XENE) earnings date: Nov 2, 2026
Xenon Pharmaceuticals (XENE) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 2, 2026, after the close. Analysts expect EPS of -$1.17.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on XENE
| Last price | $37.41 (-0.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.7% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Xenon Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Xenon Pharmaceuticals reports on Nov 2, 2026. One email the day before, with ATLAS’s read on Xenon Pharmaceuticals. You can switch it off at any time.
Alert me before XENE reportsFree to start. Creating an account takes under a minute.
XENE earnings at a glance
| Next report (confirmed) | Mon, Nov 2, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.17 |
| Last report | Aug 6, 2026 · Beat |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | -0.3% |
| Average move around a report | ±2.6% (last 4) |
| Sector | Healthcare · Biotechnology |
Xenon Pharmaceuticals earnings history: last 4 reports
Xenon Pharmaceuticals last reported on Aug 6, 2026: EPS of -$1.11 against an estimate of -$1.16 (+4.3% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$1.16 | -$1.11 | +4.3% | Beat | -1.5% |
| Jul 23, 2026 | $3.32 | $3.52 | +6.0% | Beat | -1.2% |
| Jun 25, 2026 | -$0.14 | -$0.16 | -14.3% | Miss | +7.5% |
| May 12, 2026 | $0.68 | $0.70 | +2.9% | Beat | +0.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for XENE
See the fair value, the probability range and the earnings history of Xenon Pharmaceuticals on its ATLAS page.
Xenon Pharmaceuticals (XENE) stock analysisPlans from €3.99 a month.
Xenon Pharmaceuticals earnings: frequently asked questions
When does Xenon Pharmaceuticals (XENE) report earnings?
Xenon Pharmaceuticals is scheduled to report on Monday, November 2, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for XENE?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.17 per share (USD). Estimates can change before the report.
How often does XENE beat earnings estimates?
Of its last 4 reports with a recorded result, Xenon Pharmaceuticals beat the EPS estimate 3 times; the average surprise was -0.3%. Past results do not predict the next one.
How much does XENE move around earnings?
Over its last 4 reports the stock moved an average of 2.6% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did Xenon Pharmaceuticals beat earnings estimates last quarter?
Xenon Pharmaceuticals last reported on Aug 6, 2026: EPS of -$1.11 against an estimate of -$1.16 (+4.3% surprise), a beat.
How much does XENE usually move in a day?
On a normal trading day the ATLAS model puts XENE’s one-day range at about ±3.7%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 2, 2026
Educational information, not investment advice. Disclaimer